Ovintiv (OVV) EBT (2018 - 2026)

Ovintiv (OVV) has reported EBT for 9 consecutive years, with $539.0 million the latest figure, recorded in Q2 2026.

• Quarterly EBT rose 35.09% year-over-year to $539.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $721.0 million (up 8.75% YoY) and the FY2025 annual result came in at $1.2 billion, down 10.07% from the prior year.
• EBT grew to $539.0 million in Q2 2026 per OVV's latest filing, from -$827.0 million in the prior quarter.
• Over the last five years, EBT for OVV reached as high as $1.4 billion in Q2 2022 and fell as low as -$827.0 million in Q1 2026.
• A 5-year average of $463.8 million and a median of $451.5 million in 2023 frame the typical range for EBT.
• Annual changes were most pronounced in 2022 — EBT soared 1894.37% — and 2026, when it sank 328.5%.
• Year by year, EBT stood at $1.1 billion in 2022, then decreased by 3.87% to $1.1 billion in 2023, then slumped by 109.47% to -$101.0 million in 2024, then soared by 908.91% to $817.0 million in 2025, then plunged by 34.03% to $539.0 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $539.0 million, -$827.0 million, and $817.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.